Giant Biogene Holding Co (HKSE:02367) Total Assets : HK$5,439 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Total Assets?

Giant Biogene Holding Co's Total Assets for the quarter that ended in Dec. 2023 was HK$5,439 Mil.

During the past 12 months, Giant Biogene Holding Co's average Total Assets Growth Rate was 24.30% per year. During the past 3 years, the average Total Assets Growth Rate was 16.60% per year.

During the past 5 years, Giant Biogene Holding Co's highest 3-Year average Total Assets Growth Rate was 16.60%. The lowest was -1.10%. And the median was 7.75%.

Total Assets is connected with ROA %. Giant Biogene Holding Co's annualized ROA % for the quarter that ended in Dec. 2023 was 35.47%. Total Assets is also linked to Revenue through Asset Turnover. Giant Biogene Holding Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.43.

Giant Biogene Holding Co Total Assets Historical Data

The historical data trend for Giant Biogene Holding Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Total Assets Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

1,999.54

3,142.71

9,646.61

3,504.50

5,439.45

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial			9,646.61	-	3,504.50	4,241.70	5,439.45

Giant Biogene Holding Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Giant Biogene Holding Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	4780.962	+	658.486
	=	5,439

Giant Biogene Holding Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	4780.962	+	658.486
	=	5,439

Giant Biogene Holding Co (HKSE:02367) Total Assets Explanation

Total Assets is connected with ROA %.

Giant Biogene Holding Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	1716.824	/	( (4241.702	+	5439.448)	/ 2 )
	=	1716.824	/	4840.575
	=	35.47 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Giant Biogene Holding Co's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	2098.355	/	( (4241.702	+	5439.448)	/ 2 )
=	2098.355	/	4840.575
=	0.43

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Giant Biogene Holding Co Total Assets Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Executives

Refulgence Holding Limited	2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd	2101 Beneficial owner
Fan Daidi	2201 Interest of corporation controlled by you
Yan Jianya	2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Yan Jianya	2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited	2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines